Heykants J - Search Results

1

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

Huang ML, Van Peer A, Woestenborghs R, De Coster R, Heykants J, Jansen AA, Zylicz Z, Visscher HW, Jonkman JH. Huang ML, et al. Among authors: heykants j. Clin Pharmacol Ther. 1993 Sep;54(3):257-68. doi: 10.1038/clpt.1993.146. Clin Pharmacol Ther. 1993. PMID: 7690693

2

Absorption, metabolism, and excretion of risperidone in humans.

Mannens G, Huang ML, Meuldermans W, Hendrickx J, Woestenborghs R, Heykants J. Mannens G, et al. Among authors: heykants j. Drug Metab Dispos. 1993 Nov-Dec;21(6):1134-41. Drug Metab Dispos. 1993. PMID: 7507814

3

The pharmacokinetics of risperidone in humans: a summary.

Heykants J, Huang ML, Mannens G, Meuldermans W, Snoeck E, Van Beijsterveldt L, Van Peer A, Woestenborghs R. Heykants J, et al. J Clin Psychiatry. 1994 May;55 Suppl:13-7. J Clin Psychiatry. 1994. PMID: 7520903

4

Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man.

Snoeck E, Van Peer A, Sack M, Horton M, Mannens G, Woestenborghs R, Meibach R, Heykants J. Snoeck E, et al. Among authors: heykants j. Psychopharmacology (Berl). 1995 Dec;122(3):223-9. doi: 10.1007/BF02246543. Psychopharmacology (Berl). 1995. PMID: 8748391 Clinical Trial.

5

Pharmacokinetics of lubeluzole (Prosynap) after single intravenous doses in healthy subjects.

Van de Velde V, Crabbe R, Van Peer A, Woestenborghs R, Van Osselaer N, Hantson L, Heykants J. Van de Velde V, et al. Among authors: heykants j. Int J Clin Pharmacol Ther. 1998 Sep;36(9):490-3. Int J Clin Pharmacol Ther. 1998. PMID: 9760010 Clinical Trial.

6

Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.

Bowden CR, Voina SJ, Woestenborghs R, De Coster R, Heykants J. Bowden CR, et al. Among authors: heykants j. J Pharmacol Exp Ther. 1992 Aug;262(2):699-706. J Pharmacol Exp Ther. 1992. PMID: 1380082

7

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

Van Peer A, Woestenborghs R, Heykants J, Gasparini R, Gauwenbergh G. Van Peer A, et al. Among authors: heykants j. Eur J Clin Pharmacol. 1989;36(4):423-6. doi: 10.1007/BF00558308. Eur J Clin Pharmacol. 1989. PMID: 2544431 Clinical Trial.

8

Absorption, metabolism and excretion of ketanserin in man after oral administration.

Meuldermans W, Hendrickx J, Woestenborghs R, Van Peer A, Lauwers W, De Cree J, Heykants J. Meuldermans W, et al. Among authors: heykants j. Arzneimittelforschung. 1988 Jun;38(6):789-94. Arzneimittelforschung. 1988. PMID: 3178919

9

Hypnoanalgesia with R 8110/fentanyl in the dog: pharmacodynamic and pharmacokinetic interactions.

Monbaliu J, Degryse AD, Ooms LA, Van Dijk P, Lagerweij E, Michiels M, Woestenborghs R, Heykants J. Monbaliu J, et al. Among authors: heykants j. J Vet Pharmacol Ther. 1988 Mar;11(1):63-70. doi: 10.1111/j.1365-2885.1988.tb00122.x. J Vet Pharmacol Ther. 1988. PMID: 3379665

10

Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.

Heykants J, Van Peer A, Woestenborghs R, Gould S, Mills J. Heykants J, et al. Eur J Clin Pharmacol. 1986;31(3):343-50. doi: 10.1007/BF00981135. Eur J Clin Pharmacol. 1986. PMID: 3792432 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters